© 1999 Canadian Medical Association representativeness, because the care is
administered by specific providers and may in some instances be provided to a specific …

PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS who treat patients with
human immunodeficiency virus (HIV)/AIDS are confronted daily with complex challenges …

Background No large clinical end-point trials have been conducted comparing regimens
among human immunodeficiency virus type 1–positive persons starting antiretroviral …

Purpose: The purpose of our study was to make an assessment of the HIV patients' overall
opinion of therapeutic trials, to analyze the motivations and the reasons linked to this …

Background The generalizability of antiretroviral therapy (ART) clinical trial efficacy findings
to routine care settings is not well studied. We compared the relative effectiveness of initial …

ObjectiveNew information warrants updated recommendations for the 4 central issues in
antiretroviral therapy: when to start, what drugs to start with, when to change, and what to …

ContextGuidelines for antiretroviral therapy are important for clinicians worldwide given the
complexity of the field and the varied clinical situations in which these agents are used. The …

Objectives: It is important to assess the extent of bias when comparing the clinical efficacy of
antiretroviral regimens in observational databases because, with the current lack of planned …

Objectives To compare the effectiveness of first protease inhibitor (PI)-containing and non-
nucleoside reverse transcriptase inhibitor (NNRTI)-containing regimens. Methods Data were …

Many arguments have been raised over the years to justify not moving rapidly forward with
antiretroviral treatment programs for people living with the human immunodeficiency virus …